-+ 0.00%
-+ 0.00%
-+ 0.00%

CSPC Group announced that the plugliptin dagliflozin metformin sustained-release tablets developed by the Group have been approved by the State Drug Administration and can conduct clinical trials in China.

Zhitongcaijing·12/29/2025 10:33:08
Listen to the news
CSPC Group announced that the plugliptin dagliflozin metformin sustained-release tablets developed by the Group have been approved by the State Drug Administration and can conduct clinical trials in China.